A detailed history of Bank Of America Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Bank Of America Corp holds 1,961,175 shares of ALKS stock, worth $57.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,961,175
Previous 1,957,100 0.21%
Holding current value
$57.4 Million
Previous $53 Million 10.79%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.21 - $27.24 $94,580 - $111,003
4,075 Added 0.21%
1,961,175 $47.3 Million
Q1 2024

May 15, 2024

BUY
$26.4 - $32.56 $15 Million - $18.5 Million
567,941 Added 40.88%
1,957,100 $53 Million
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $16 Million - $19.7 Million
686,270 Added 97.64%
1,389,159 $38.5 Million
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $14.2 Million - $16.8 Million
-499,633 Reduced 41.55%
702,889 $22 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $12.6 Million - $14.5 Million
499,186 Added 70.97%
1,202,522 $33.9 Million
Q4 2022

Feb 10, 2023

BUY
$21.94 - $26.24 $1.63 Million - $1.94 Million
74,070 Added 11.77%
703,336 $18.4 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $3.92 Million - $5.68 Million
178,134 Added 39.49%
629,266 $14.1 Million
Q2 2022

Aug 12, 2022

BUY
$26.4 - $30.54 $237 - $274
9 Added 0.0%
451,132 $13.4 Million
Q1 2022

May 16, 2022

BUY
$23.07 - $27.99 $2.57 Million - $3.12 Million
111,510 Added 32.83%
451,123 $11.9 Million
Q4 2021

Feb 08, 2022

BUY
$21.47 - $32.08 $778,931 - $1.16 Million
36,280 Added 11.96%
339,613 $7.9 Million
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $824,516 - $1.13 Million
35,281 Added 13.16%
303,333 $9.35 Million
Q2 2021

Sep 13, 2021

BUY
$18.78 - $25.15 $5.03 Million - $6.74 Million
268,052 New
268,052 $6.57 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.81B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.